☆ 4.1 Article

Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs

JOURNAL OF MEDICAL ECONOMICS (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Persisting cancer mortality gap between western and eastern Europe

Claudia Santucci et al.

Summary: In Europe, there has been a favorable trend in cancer mortality over the past three decades, but this trend has been less favorable for most eastern European countries. While cancer mortality rates have been declining in western Europe since 1990, rates in eastern Europe only started to decline in the 2000s for men and remained stable for women. The mortality rates for lung cancer and other cancers are higher in eastern Europe compared to western Europe. Differences in lifestyle patterns and the implementation of improvements in cancer diagnosis and management contribute to the persisting disparity in cancer mortality between western and eastern Europe.

EUROPEAN JOURNAL OF CANCER (2022)

Add to Collection

Article Health Policy & Services

Lost productivity due to head and neck cancer mortality in Hungary, Poland, and Romania

Goran Bencina et al.

Summary: Head and neck cancer leads to significant mortality burden and productivity losses in Hungary, Poland, and Romania. The total PVFLP due to premature HNC-related deaths in these countries is estimated to be euro 449 million, highlighting the importance of reducing the burden of HNC through multidisciplinary approaches including prevention policies and improved diagnostic techniques. Reducing the burden of HNC not only decreases productivity losses but also has a positive impact on other cancer indications and related illnesses.

JOURNAL OF CANCER POLICY (2022)

Add to Collection

Article Oncology

Correlation between work productivity loss and EORTC QLQ-C30 and-BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2-advanced breast cancer

Debu Tripathy et al.

Summary: This post hoc analysis explored the correlation between work productivity loss (WPL) and different domains of quality of life in premenopausal women with HR+/HER2- advanced breast cancer.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+and Triple-Negative Breast Cancer

Lorena Gonzalez et al.

Summary: Recent studies suggest that de-escalation of systemic therapy, especially in early-stage Her2+ and triple-negative breast cancer, may be an effective strategy to improve short-term outcomes. Further prospective research is needed to determine the safety and efficacy of omitting systemic therapy in triple-negative breast cancer.

CURRENT BREAST CANCER REPORTS (2021)

Add to Collection

Article Oncology

The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers

Tadeusz Dyba et al.

Summary: This article presents the incidence and mortality estimates for 25 major cancers across 40 individual countries within European areas and the EU-27 for the year 2020. The most common cancers are breast, colorectal, lung, and prostate cancers, which account for half the overall cancer burden in Europe. The estimates provide a basis for setting priorities in cancer-control measures across Europe.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Review Medicine, General & Internal

Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities

Sylvia Annabel Dass et al.

Summary: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with no expression of certain receptors, leading to a poor prognosis and high relapse rate. Improved diagnostic and subtype classification methods are crucial for personalized treatment strategies and enhanced efficacy.

MEDICINA-LITHUANIA (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Economics

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands

Paul Peter Schneider et al.

Summary: This study provides detailed information on hospital resource use and associated costs of patients with advanced breast cancer in The Netherlands. The results show significant variability in lifetime hospital costs, with systemic therapies being the primary cost driver.

VALUE IN HEALTH (2021)

Add to Collection

Article Oncology

European trends in breast cancer mortality, 1980-2017 and predictions to 2025

Cezary Wojtyla et al.

Summary: Breast cancer mortality rates have been falling in most European countries, with the most significant decreases observed in countries like Denmark. However, less favorable patterns were still observed among transitional countries compared to other European areas.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Review Health Care Sciences & Services

Breast Cancer Treatments: Updates and New Challenges

Anna Burguin et al.

Summary: Breast cancer, the most frequent cancer diagnosed in women worldwide, can be classified into four molecular subtypes for personalized treatment targeting receptors, but resistance and adverse effects remain challenges. Treatments for TNBC and other subgroups are still not standardized, with emerging approaches like immunotherapy and targeting other metabolic pathways gaining attention.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Oncology

The cost of cancer in Europe 2018

Thomas Hofmarcher et al.

EUROPEAN JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

Productivity costs associated with metastatic breast cancer in younger, midlife, and older women

Justin G. Trogdon et al.

CANCER (2020)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Do we still need breast cancer screening in the era of targeted therapies and precision medicine?

Rubina Manuela Trimboli et al.

INSIGHTS INTO IMAGING (2020)

Add to Collection

Review Oncology

Recent Advances in the Treatment of Breast Cancer

Christy W. S. Tong et al.

FRONTIERS IN ONCOLOGY (2018)

Add to Collection

Article Oncology

Triple-negative breast cancer: is there a treatment on the horizon?

Hui Yao et al.

ONCOTARGET (2017)

Add to Collection

Article Health Care Sciences & Services

Women With Breast Cancer Who Work For Accommodating Employers More Likely To Retain Jobs After Treatment

Victoria Blinder et al.

HEALTH AFFAIRS (2017)

Add to Collection

Article Oncology

Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014

Blazej Lyszczarz et al.

BMC CANCER (2017)

Add to Collection

Review Biology

Awareness and current knowledge of breast cancer

Muhammad Akram et al.

BIOLOGICAL RESEARCH (2017)

Add to Collection

Editorial Material Oncology

Cancer Control in Central and Eastern Europe

Carlo La Vecchia et al.

ONCOLOGIST (2016)

Add to Collection

Article Oncology

International Variation in Female Breast Cancer Incidence and Mortality Rates

Carol E. DeSantis et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)

Add to Collection

Article Oncology

Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer-related mortality in Europe

Paul Hanly et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Add to Collection

Article Oncology

Economic burden of cancer across the European Union: a population-based cost analysis

Ramon Luengo-Fernandez et al.

LANCET ONCOLOGY (2013)

Add to Collection

Article Medicine, General & Internal

Indirect costs associated with metastatic breast cancer

Yin Wan et al.

JOURNAL OF MEDICAL ECONOMICS (2013)

Add to Collection

Editorial Material Medicine, General & Internal

Cancer epidemiology in Central and South Eastern European countries

Eduard Vrdoljak et al.

CROATIAN MEDICAL JOURNAL (2011)

Add to Collection

Article Oncology

Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer

William F. Anderson et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Add to Collection

Article Economics

Employment-contingent health insurance, illness, and labor supply of women: evidence from married women with breast cancer

Cathy J. Bradley et al.

HEALTH ECONOMICS (2007)

Add to Collection

Article Medicine, General & Internal

Work absence after breast cancer diagnosis:: a population-based study

M Drolet et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)

Add to Collection

Article Medicine, General & Internal

Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality

RG Blanks et al.

BRITISH MEDICAL JOURNAL (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.